Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_assertion type Assertion NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_head.
- NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_assertion description "[HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_provenance.
- NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_assertion evidence source_evidence_literature NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_provenance.
- NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_assertion SIO_000772 15899817 NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_provenance.
- NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_assertion wasDerivedFrom befree-20150227 NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_provenance.
- NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_assertion wasGeneratedBy ECO_0000203 NP380876.RAZahv3blsdoTp-rnnsSZskG0Zm0SbUGzSBu-L-2PfdJ4130_provenance.